- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 30.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::CASH DIVIDEND/DISTRIBUTION::MANDATORY | 2 | SGX Company Announcements | ||
| 25.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 5TH BOARD MEETING FOR FY2026 | 4 | SGX Company Announcements | ||
| 22.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 2 | SGX Company Announcements | ||
| 03.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE ANNUAL GENERAL MEETING OF THE COMPANY HELD ON 15 MAY 2026 | - | SGX Company Announcements | ||
| 02.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | - | SGX Company Announcements | ||
| 02.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 19.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED TRANSFER OF 100% EQUITY INTEREST IN AN UPSTREAM SHAREHOLDER | 1 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::ANNOUNCEMENT OF APPOINTMENT | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 5 | SGX Company Announcements | ||
| 11.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Increase In Q1 Income | 5 | RTTNews | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE EVALUATION REPORT ON THE 2025 ACTION PLAN AND THE ADOPTION OF THE 2026 ACTION PLAN | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 4TH BOARD MEETING FOR FY2026 | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FIRST QUARTER RESULTS | - | SGX Company Announcements | ||
| 16.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 148,50 | -1,23 % | BERNSTEIN RESEARCH stuft ASTRAZENECA auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Astrazeneca von 18600 auf 18900 Pence angehoben und die Einstufung auf "Outperform" belassen. Vielversprechende... ► Artikel lesen | |
| TEVA | 28,100 | -2,77 % | Polpharma Biologics International AG: Teva und Polpharma Biologics geben globale Lizenzvereinbarung für einen Biosimilar-Kandidaten zu Ocrevus (Ocrelizumab) zur Behandlung von Multipler Sklerose bekannt | Teva sichert sich die exklusiven weltweiten Rechte zur Vermarktung des Biosimilar-Kandidaten von Polpharma Biologics für Ocrevus (Ocrelizumab), einschließlich intravenöser und subkutaner Darreichungsformen... ► Artikel lesen | |
| SINOPHARM | 1,910 | +2,03 % | Daiwa Downgrades SINOPHARM to Hold, Cuts TP to HKD18 | ||
| CSPC PHARMA | 0,916 | +0,88 % | CSPC PHARMA Receives USD25 million Milestone Payment From AstraZeneca PLC Ordinary Shares | ||
| WUXI BIOLOGICS | 4,115 | -2,60 % | WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy | SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO)... ► Artikel lesen | |
| OPKO HEALTH | 1,230 | +3,36 % | OPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results | MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,861 | +1,58 % | Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution | SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter... ► Artikel lesen | |
| GEDEON RICHTER | 33,940 | +1,62 % | Gedeon Richter Plc.: Interest payment / Principal repayment | ||
| DR REDDYS | 11,700 | 0,00 % | Dr Reddys Laboratories Ltd slips for fifth straight session | ||
| BAYER | 49,810 | -1,76 % | Märkte am Morgen: Bayer, Deutsche Bank, SAP, Delivery Hero, Easyjet, ASML | Der DAX hat in der vergangenen Woche abgeliefert. Ein Plus von 4,5 Prozent bedeutet die beste Handelswoche seit April 2025. Vor allem an den letzten Tagen blies der DAX zur Rekordjagd, stellte eine... ► Artikel lesen | |
| MERCK KGAA | 139,15 | -0,32 % | Aktien Frankfurt Ausblick: Dax kaum bewegt nach Rekord | FRANKFURT (dpa-AFX) - Nach seinem Rekordlauf in der vergangenen Woche dürfte der Dax am Montag seine Gewinne halten. Stützend wirken teils freundliche Aktienmärkte in Asien. Dort sorge die Aussicht... ► Artikel lesen | |
| NOVO NORDISK | 43,090 | -0,66 % | Novo Nordisk: Kursziel rauf | Stück für Stück arbeitet sich die Aktie von Novo Nordisk aus dem Tal der Tränen. Zum Start in die neue Handelswoche verbucht das Papier des dänischen Biopharma-Konzerns an der Heimatbörse in Kopenhagen... ► Artikel lesen | |
| PMGC | 1,110 | -0,89 % | PMGC Holdings Inc.: NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression | Independent flow cytometry (FACS) study will quantify latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei and establish comparability against EL-22 material previously... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,540 | -0,15 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 77,84 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen |
Das Unternehmen TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,64 % bei einem Aktienkurs von 2,480 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.